Medicinal chemistry – Page 9
-
ResearchCoca plants’ production pathway for cocaine finally unravelled
167-year-old biosynthetic mystery may be solved
-
ResearchRadium chelator researchers working to improve targeted cancer therapies
Oak Ridge National Lab team investigate factors underpinnning Ra2+ complex stability and selectivity in attempt to expand the therapeutic utility of radium-223
-
OpinionEmbracing oddities
When new chemistry looks like alchemy or witchcraft, it’s worth taking notice
-
ArticleThermal analysis in the development of long-acting injectable systems
Evaluating new polymers for slow-release drug delivery could deliver better treatment for patients
-
NewsWorld Health Organization takes aim at market as many still not getting vaccines they need
Government, industry and health organisations must do more
-
WebinarAnalytical impurity standards – minimise project risk & avoid common pitfalls
Learn how to save time and money by understanding what’s at stake when working with analytical impurity standards.
-
NewsAlarm sounded after chemists discover new analogue of ketamine in Australia
Long-term health effects of novel psychoactive substance are unknown
-
ResearchGut bacterium found to destroy nicotine offers liver health benefits for smokers
Discovery might lead to therapy for non-alcoholic fatty liver disease
-
ArticleInspiring a new era of patient-centric medicines
Christian Jones discusses new formulations for drug delivery that put people first
-
ResearchDiverse pharmaceutical building blocks prepared with evolved enzymes
Computation guides enzyme evolution to produce high-value drug compounds
-
-
-
ResearchAmide library created at speed with machine learning and stopped-flow chemistry
Approach used 90% less starting material than continuous flow equivalent
-
FeatureTiny delivery systems for cancer drugs
Encapsulating anticancer agents in nanoparticles can make them gentler on the rest of the body. Clare Sansom reports
-
OpinionNobel vision
Looking beyond the here-and-now let click chemistry open up a whole new world of possibility
-
BusinessAlzheimer’s antibody engenders anticipation
Tantalising press-released data on Biogen and Eisai’s lecanemab prompt questions without firm answers
-
BusinessAn evolution in pharma outsourcing
Contract services firms are becoming increasingly sophisticated and embedded in the ecosystem of drug development
-
OpinionThe end of a long race?
The finishing line of the Covid-19 pandemic may be in sight, but we mustn’t stop running just yet
-
FeatureCan we clean Covid from the air around us?
Nina Notman talks to the experts about what is needed to remove pollutants and even infectious diseases from the air inside our homes, schools and offices
-
OpinionContribute to defeating malaria
The Medicines for Malaria Venture needs new compounds for screening and more chemists to join its open-souce drug discovery project